40 Stocks Moving In Monday's Mid-Day Session

Loading...
Loading...

Gainers

  • Minerva Neurosciences Inc NERV climbed 48.9% to $6.30 after the company announced that its Phase 2B trial for the clinical trial of Seltorexant achieved its primary and key secondary objectives.
  • PCM, Inc. PCMI shares gained 42.5% to $34.73 after Insight announced plans to acquire PCM for $35 per share.
  • VivoPower International PLC VVPR rose 34.2% to $1.3690 after the company announced new international parties have engaged in the company's solar portfolio sale. The company also announced additional contracts relating to solar farms and data centers.
  • Krystal Biotech Inc KRYS climbed 26.5% to $36.87 after the company announced positive results from its Phase 2 clinical trial of KB103 and received regenerative medicine advanced therapy designation from FDA.
  • NRC Group Holdings Corp NRCG shares rose 24.6% to $11.00 after US Ecology, Inc. ECOL announced plans to acquire NRC Group for $12 per share in US Ecology stock.
  • Technical Communications Corporation TCCO rose 18.2% to $4.15. Technical Communications completed restatement of prior financial statements and filed its Annual Report on Form 10-K for the fiscal year ended September 29, 2018.
  • Del Frisco's Restaurant Group Inc DFRG shares climbed 16.8% to $7.86 after the company announced it will be acquired by L Catterton for $8 per share.
  • Caesars Entertainment Corporation CZR rose 15% to $11.49 after the company announced it will be acquired by Eldorado Resorts for $8.50 per share in cash plus 0.0899 share of Eldorado common stock.
  • Rudolph Technologies, Inc. RTEC gained 9.3% to $27.36 after the company announced a merger with Nanometrics Incorporated NANO.
  • Moxian, Inc. MOXC gained 9.3% to $2.83.
  • Tailored Brands, Inc. TLRD shares rose 8.2% to $6.01. Tailored Brands declared a quarterly cash dividend of $0.18 per share.
  • Prevail Therapeutics Inc. PRVL shares surged 8.1% to $15.68.
  • Harrow Health, Inc. HROW shares rose 8% to $7.50.
  • Qudian Inc. QD shares jumped 7.8% to $8.81 on continued momentum after the company raised its FY19 guidance.
  • MediWound Ltd. MDWD gained 7.7% to $3.23.
  • CEL-SCI Corporation CVM jumped 7.7% to $8.65.
  • Mesoblast Limited MESO rose 7.1% to $5.00 after the company’s heart failure cell therapy received Orphan Drug designation from the FDA for prevention of gastrointestinal bleeding in patients with left ventricular assist devices.
  • Riot Blockchain, Inc. RIOT rose 6.2% to $2.92 after surging 5.77% on Friday.
  • Concert Pharmaceuticals Inc CNCE climbed 6.1% to $11.57 after SunTrust Robinson Humphrey initiated coverage on the stock with a Buy rating and a price target of $30 per share.
  • Waitr Holdings Inc WTRH gained 4.8% to $5.78 after RBC Capital initiated coverage on the stock with an Outperform rating and a $10 price target.
  • Morphosys Ag MOR gained 4.6% to $26.20 after the company presented primary analysis data for its L-MIND study for Tafasitamab.
  • Palatin Technologies, Inc. PTN climbed 3.5% to $1.3856 after the FDA granted marketing approval to AMAG Pharmaceuticals' Vyleesi, triggering a $60 million milestone payment to Palatin under its North American license agreement with AMAG .


Check out these big penny stock gainers and losers

Losers

  • The Peck Company, Inc. PECK shares tumbled 23% to $8.54 after falling 34.9% on Friday.
  • Pier 1 Imports, Inc. PIR dropped 21.9% to $8.85 after dropping 23.5% on Friday. Pier 1 Imports announced a 1-for-20 reverse stock split Wednesday to regain compliance with New York Stock Exchangelisting standards. The company’s board of directors formally authorized a 1-for-20 reverse stock split of Pier 1’s common stock effective Thursday.
  • Avinger, Inc. AVGR shares declined 17.4% to $3.45.
  • 360 Finance, Inc. QFIN dropped 15.1% to $11.71 after the company announced a proposed follow-on public offering of 7.5 million American depositary shares.
  • Axovant Gene Therapies Ltd. AXGT dipped 10.6% to $6.13.
  • Seadrill Limited SDRL shares fell 10.6% to $3.54.
  • Precision BioSciences, Inc. DTIL dropped 10.3% to $13.21.
  • Affimed N.V. AFMD shares declined 9.8% to $3.0750 after announcing clinical data update on lead product candidate AFM13 in CD30+ lymphoma at the ICML 2019.
  • OncoCyte Corporation OCX shares dropped 9.7% to $3.89.
  • GTT Communications, Inc. GTT shares tumbled 9.5% to $20.68.
  • Beyond Meat, Inc. BYND fell 9.3% to $139.88 after dropping 6.68% on Friday.
  • uniQure N.V. QURE dropped 8.9% to $74.88.
  • Greenlane Holdings, Inc. GNLN dipped 8.9% to $9.40.
  • Allena Pharmaceuticals, Inc. ALNA shares fell 8.7% to $4.2559.
  • Eldorado Resorts, Inc. ERI fell 8.4% to $46.92 after the company announced it will acquire Caesars Entertainment for $8.50 per share and 0.0899 share of common stock. The company also announced to sell the land of 3 casino properties to VICI Properties for $3.
  • Akerna Corp. KERN fell 8.3% to $24.81 after falling 25.99% on Friday.
  • Bristol-Myers Squibb Company BMY fell 6.9% to $45.95 after the company announced its CheckMate -459 study evaluating Opdivo did not reach its primary endpoint and announced plans to sell OTEZLA to help ease FTC concerns regarding its acquisition of Celgene.
  • Celgene Corporation CELG fell 4.6% to $94.33 after the company announced it continues to receive FTC concerns regarding the pending merger with Bristol-Myers Squibb.
Loading...
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralInformation TechnologyLosersSemiconductor EquipmentTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...